September 14, 2021 Comments Off on New patent for Genentech Inc drug ROZLYTREK Posted in: Patent Added Annual Drug Patent Expirations for ROZLYTREK Rozlytrek is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are twelve patents…
The post New patent for Genentech Inc drug ROZLYTREK appeared first on D…
September 14, 2021 Comments Off on New patent for Sanofi Aventis drug JEVTANA KIT Posted in: Patent Added Annual Drug Patent Expirations for JEVTANA+KIT Jevtana Kit is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There are…
The post New patent for Sanofi Aventis drug JEVTANA KIT appeared first on DrugP…